NGL Fine Chem P/E Ratio

NGLFINE • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
36.66
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 36.66
Current Price ₹2331.40
EPS (TTM) ₹34.19
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 34.34
Historical Range 16.95 - 62.26
Percentile 66.7%

Sector Context

Sector Average 47.57
Sector Median 25.5
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹56.82
Sept 2025 ₹15.58
Mar 2025 ₹0.88

Key P/E Ratio Insights for NGL Fine Chem

  • Stock appears overvalued with PE of 36.66, suggesting caution for new investments
  • Trading at discount to sector average PE of 47.57

P/E Ratio Historical Trend for NGL Fine Chem

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 31.72 56.82 ₹1802.15 NSE High
2024 40.9 52.82 ₹2160.55 NSE High
2023 24.81 62.06 ₹1539.75 NSE Moderate
2022 62.26 30.02 ₹1868.95 NSE High
2021 29.38 91.98 ₹2702.40 BSE High
2019 16.95 25.05 ₹424.65 BSE Moderate

Sector P/E Ratio Comparison

Comparing NGL Fine Chem with other companies in Healthcare sector
Sector Average
47.57
Sector Median
25.5
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low